Design and Synthesis of Serine and Aspartic Protease Inhibitors

作者: Fredrik Wångsell

DOI:

关键词: SerineIn vitroCyclopenteneAmino acidProteaseChemistryNS3Aspartate proteaseStereochemistryHcv ns3 protease

摘要: Potent tetrapeptidic inhibitors of the HCV NS3 protease have been developed incorporating 4-hydroxy-cyclopent-2-ene-1,2-dicarboxylic acid as a new N-acyl-l-hydroxyproline mimic. The hydroxycyclopentene template was synthesized in eight steps from commercially available (syn)-tetrahydrophthalic anhydride. Three different amino acids were explored P1-position and P2-position hydroxyl group cyclopentene substituted with 7-methoxy-2-phenyl-quinolin-4-ol. P3/P4-positions then optimized set six derivatives. All evaluated an vitro assay using full-length protease. Several potent identified, most promising exhibiting Ki value 1.1 nM.

参考文章(86)
B. Robertson, G. Myers, C. Howard, T. Brettin, J. Bukh, B. Gaschen, T. Gojobori, G. Maertens, M. Mizokami, O. Nainan, S. Netesov, K. Nishioka, T. Shin-i, P. Simmonds, D. Smith, L. Stuyver, A. Weiner, Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization Archives of Virology. ,vol. 143, pp. 2493- 2503 ,(1998) , 10.1007/S007050050479
MinKyung Yi, Xiao Tong, Angela Skelton, Robert Chase, Tong Chen, Andrew Prongay, Stephane L. Bogen, Anil K. Saksena, F. George Njoroge, Ronald L. Veselenak, Richard B. Pyles, Nigel Bourne, Bruce A. Malcolm, Stanley M. Lemon, Mutations Conferring Resistance to SCH6, a Novel Hepatitis C Virus NS3/4A Protease Inhibitor Journal of Biological Chemistry. ,vol. 281, pp. 8205- 8215 ,(2006) , 10.1074/JBC.M510246200
L. Thompson, J. Bronson, F. Zusi, Progress in the discovery of BACE inhibitors. Current Pharmaceutical Design. ,vol. 11, pp. 3383- 3404 ,(2005) , 10.2174/138161205774370825
Peter Simmonds, The origin and evolution of hepatitis viruses in humans. Journal of General Virology. ,vol. 82, pp. 693- 712 ,(2001) , 10.1099/0022-1317-82-4-693
BA Malcolm, R Liu, F Lahser, S Agrawal, B Belanger, N Butkiewicz, R Chase, F Gheyas, A Hart, D Hesk, P Ingravallo, C Jiang, R Kong, J Lu, J Pichardo, A Prongay, A Skelton, X Tong, S Venkatraman, E Xia, V Girijavallabhan, FG Njoroge, None, SCH 503034, a Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease, Suppresses Polyprotein Maturation and Enhances the Antiviral Activity of Alpha Interferon in Replicon Cells Antimicrobial Agents and Chemotherapy. ,vol. 50, pp. 1013- 1020 ,(2006) , 10.1128/AAC.50.3.1013-1020.2006
D R Davies, The structure and function of the aspartic proteinases. Annual Review of Biophysics and Biophysical Chemistry. ,vol. 19, pp. 189- 215 ,(1990) , 10.1146/ANNUREV.BB.19.060190.001201
M. I. Memon, M. A. Memon, Hepatitis C: an epidemiological review Journal of Viral Hepatitis. ,vol. 9, pp. 84- 100 ,(2002) , 10.1046/J.1365-2893.2002.00329.X
Nathalie Goudreau, Christian Brochu, Dale R. Cameron, Jean-Simon Duceppe, Anne-Marie Faucher, Jean-Marie Ferland, Chantal Grand-Maître, Martin Poirier, Bruno Simoneau, Youla S. Tsantrizos, Potent inhibitors of the hepatitis C virus NS3 protease: design and synthesis of macrocyclic substrate-based beta-strand mimics. Journal of Organic Chemistry. ,vol. 69, pp. 6185- 6201 ,(2004) , 10.1021/JO049288R
V. R. N. MUNASINGHE, Synthesis of Deoxy Sugars ChemInform. ,vol. 20, ,(1989) , 10.1002/CHIN.198928346
T L Blundell, A Albert, V Dhanaraj, K Guruprasad, M Williams, B L Sibanda, The aspartic proteinases. An historical overview. Advances in Experimental Medicine and Biology. ,vol. 436, pp. 1- 13 ,(1998)